J
Jacques Bosq
Researcher at Institut Gustave Roussy
Publications - 141
Citations - 7333
Jacques Bosq is an academic researcher from Institut Gustave Roussy. The author has contributed to research in topics: Cancer & Chemotherapy regimen. The author has an hindex of 47, co-authored 138 publications receiving 6947 citations. Previous affiliations of Jacques Bosq include Université Paris-Saclay & Centre national de la recherche scientifique.
Papers
More filters
Journal ArticleDOI
Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease
Christophe Fermé,Houchingue Eghbali,J.H. Meerwaldt,Chantal Rieux,Jacques Bosq,Françoise Berger,Theodore Girinsky,Pauline Brice,Mars B. van't Veer,Jan Walewski,Pierre Lederlin,Umberto Tirelli,Patrice Carde,Eric Van Den Neste,Emmanuel Gyan,Mathieu Monconduit,Marine Diviné,John M. M. Raemaekers,Gilles Salles,Evert M. Noordijk,Geert Jan Creemers,Jean Gabarre,Anton Hagenbeek,Oumedaly Reman,Michel Blanc,José Thomas,B. Vie,Johanna Kluin-Nelemans,Fernando Viseu,Joke W. Baars,Philip Poortmans,Pieternella J. Lugtenburg,Christian Carrie,Jérôme Jaubert,Michel Henry-Amar +34 more
TL;DR: Chemotherapy plus involved-field radiotherapy should be the standard treatment for Hodgkin's disease with favorable prognostic features and in patients with unfavorable features, four courses of chemotherapyplus involved- field radiotherapy ought to be thestandard treatment.
Journal ArticleDOI
Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus
Panagiotis Kanavaros,Marie-Claude Lescs,Josette Brière,Marine Divine,Françoise Galateau,Irene Joab,Jacques Bosq,Jean-Pierre Farcet,Felix Reyes,Philippe Gaulard +9 more
TL;DR: The concept that NTCL constitute a distinct group of lymphomas that, in addition to their peculiar clinical features, exhibit an unusual TCR "silent" CD56+ or TCR gamma delta+ phenotype and harbor the EBV is supported.
Journal ArticleDOI
Lymph node prognostic factors in head and neck squamous cell carcinomas
TL;DR: The most significant prognostic factors are the site of the positive node in or out of the sentinel node and the number of positive nodes; and a more accurate approach can be obtained by combining both factors.
Journal ArticleDOI
Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type.
Yenlin Huang,Yenlin Huang,Aurélien de Reyniès,Laurence de Leval,Bouchra Ghazi,Nadine Martin-Garcia,Nadine Martin-Garcia,Marion Travert,Marion Travert,Jacques Bosq,Josette Brière,Barbara Petit,Emilie Thomas,Paul Coppo,Teresa Marafioti,Jean-François Emile,Marie-Hélène Delfau-Larue,Marie-Hélène Delfau-Larue,Christian Schmitt,Philippe Gaulard,Philippe Gaulard +20 more
TL;DR: Several features of NKTCL uncovered by this analysis suggest perturbation of angiogenic pathways, and this study highlights emerging oncogenic pathways inNKTCL and identifies novel diagnostic and therapeutic targets.
Journal ArticleDOI
Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review.
Tony Petrella,Martine Bagot,Rein Willemze,Marie Beylot-Barry,Béatrice Vergier,Michèle Delaunay,Chris J.L.M. Meijer,Philippe Courville,Pascal Joly,Florent Grange,Anne de Muret,Laurent Machet,Anne Dompmartin,Jacques Bosq,Anne Durlach,Philippe Bernard,Sophie Dalac,Pierre Dechelotte,Michel D'Incan,Janine Wechsler,Michael A. Teitell +20 more
TL;DR: The major clinical, histopathologic, and phenotypic aspects of the disease and diagnostic criteria and data suggesting a plasmacytoid dendritic cell origin for the tumor cells are provided.